Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRRK · against 557 other Healthcare companies listed in US-listed
Ranked #469 of 558 · scores higher than 14% of peers
Bars: peers in each 10-point band of the profitability score100 peers with a profitability score of 0–9, including SRRK · Click a bar to see the companies
Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | SRRK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -2489.4% | -7.0% | 2% | 33% | |
| Operating marginHigher is better · 479 reported | Not reported | -2.4% | — | — | 33% |
| Return on assetsHigher is better · 582 reported | -78.1% | -7.8% | 6% | 33% | |
| Return on equityHigher is better · 531 reported | -167.8% | -19.7% | 8% | Context only | |
| Gross marginHigher is better · 601 reported | 0.0% | 43.9% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 469 | 332M USD | 8 | 35 | |
| 469 | 334M USD | 8 | 49 | |
| 469 | 1.9B USD | 8 | 18 | |
| 469 | 303M USD | 8 | 27 | |
| 469 | 5.4B USD | 8 | 24 | |
| 469 | 885M USD | 8 | 33 | |
| 480 | 271M USD | 7 | 14 | |
| 480 | 257M USD | 7 | 55 | |
| 480 | 475M USD | 7 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score